DGX
44
-6
WAT
57
2
USB
57
2
VRTX
52
5
K
59
2
RF
66
2
DG
12
6
FTI
79
-2
LOW
59
9
MCO
80
5
NWSA
65
2
V
76
10
CF
50
-7
QCOM
52
3
AN
61
3
ADI
52
5
HOG
39
4
GOOG
55
5
COP
44
-9
SO
59
6
DGX
44
-6
WAT
57
2
USB
57
2
VRTX
52
5
K
59
2
RF
66
2
DG
12
6
FTI
79
-2
LOW
59
9
MCO
80
5
NWSA
65
2
V
76
10
CF
50
-7
QCOM
52
3
AN
61
3
ADI
52
5
HOG
39
4
GOOG
55
5
COP
44
-9
SO
59
6
Financhill
Back

Chugai Pharmaceutical 10K Form

Sell
32

CHGCY
Chugai Pharmaceutical

Last Price:
20.83
Seasonality Move:
5.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCY News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCY

CHGCY Financial Statistics

Sales & Book Value

Annual Sales: $7.92B
Cash Flow: $749.99M
Price / Cash Flow: 28.57
Annual Sales: $3.31
Price / Book: 6.35

Profitability

EPS (TTM): 0.78200
Net Income (TTM): $2.57B
Gross Margin: $4.98B
Return on Equity: 21.98%
Return on Assets: 20.1%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 21 years for CHGCY is 62.81%.
  • The Selling, General & Administrative Expenses for CHGCY have been equal to 10.13% of Gross Profit Margin.
  • The Research & Development expenses have been 15.73% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCY is 29.29% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCY
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.09
Quick Ratio: 4.02

Price-to-Earnings

Trailing P/E Ratio: 29.78
Forward P/E Ratio: 0

CHGCY Technical Analysis vs Fundamental Analysis

Sell
32
Chugai Pharmaceutical (CHGCY) is a Sell

Is Chugai Pharmaceutical a Buy or a Sell?